Literature DB >> 23443616

Diagnosis and management of infectious complications of childhood rheumatic diseases.

Rhina D Castillo1, Wendy De la Pena, Katherine A B Marzan.   

Abstract

Progress in the diagnosis and management of pediatric rheumatic disease has improved complications from underlying disease and the survival of children. However, as a consequence, infection has now become one of the leading causes of morbidity and mortality. Differentiating between infections and disease flares in children with rheumatic conditions can often pose diagnostic quandaries. Children with rheumatic diseases are at risk of infection, not only because of the use of immune-modulating medications but also because of underlying immune dysfunction associated with their disease. Although bacterial infections are the most common, any organism can potentially be a causative agent and, at times, more invasive measures of diagnosis, for example bronchoscopy and tissue biopsies may be necessary. Maintaining a high index of suspicion of infection with prompt diagnosis and treatment are important to further improve patient outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23443616     DOI: 10.1007/s11926-013-0322-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  100 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Gonococcal pericarditis with tamponade in a patient with systemic lupus erythematosus.

Authors:  M D Coe; D H Hamer; C S Levy; M R Milner; M H Nam; W F Barth
Journal:  Arthritis Rheum       Date:  1990-09

3.  Infections associated with juvenile systemic lupus erythematosus.

Authors:  S M Al-Mayouf; S Al-Jumaah; S Bahabri; W Al-Eid
Journal:  Clin Exp Rheumatol       Date:  2001 Nov-Dec       Impact factor: 4.473

4.  Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis.

Authors:  Boris Hugle; Melinda Solomon; Elizabeth Harvey; Adrian James; Anupma Wadhwa; Reshma Amin; Audrey Bell-Peter; Susanne Benseler
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-25       Impact factor: 4.794

5.  Outcome of patients with systemic rheumatic disease admitted to medical intensive care units.

Authors:  B Godeau; A Boudjadja; J F Dhainaut; B Schlemmer; C Chastang; F Brunet; J R Le Gall
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

Review 6.  Emerging drugs for varicella-zoster virus infections.

Authors:  Graciela Andrei; Robert Snoeck
Journal:  Expert Opin Emerg Drugs       Date:  2011-06-24       Impact factor: 4.191

7.  Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults.

Authors:  J G Gerrard
Journal:  Med J Aust       Date:  1995-03-06       Impact factor: 7.738

Review 8.  Disseminated Nocardia brasiliensis infection: an unusual complication of immunosuppressive treatment for childhood dermatomyositis.

Authors:  M S Klein-Gitelman; I S Szer
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

Review 9.  Management of rheumatic disease with comorbid HBV or HCV infection.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

10.  Hepatitis B virus reactivation in a juvenile rheumatoid arthritis patient under treatment and its successful management: a complicated case.

Authors:  Oguz Durmus; Levent Tekin; Alparslan Bayram Carli; Engin Cakar; Ali Acar; Asim Ulcay; Umit Dincer; Mehmet Zeki Kiralp
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 3.580

View more
  1 in total

1.  Real-life vaccination coverage in Slovak children with rheumatic diseases.

Authors:  Barbora Balažiová; Zuzana Kuková; Daša Mišíková; Katarína Novosedlíková; Tomáš Dallos
Journal:  Front Pediatr       Date:  2022-08-12       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.